Safety and Efficacy of Low-Dose Bexarotene and PUVA in the Treatment of Patients with Mycosis Fungoides

被引：0
|
作者：
Evangelia Papadavid
Christina Antoniou
Vassiliki Nikolaou
Marina Siakantaris
Theodoros P. Vassilakopoulos
Alexandros Stratigos
Nikolaos Stavrianeas
Andreas Katsambas
机构：
[1] Athens University Medical School,1st Department of Dermatology
[2] Skin Lymphoma Clinic,2nd Department of Dermatology
[3] A Sygros Hospital,1st Department of Internal Medicine
[4] Athens University Medical School,Haematology
[5] ATTIKON University General Hospital,undefined
[6] Athens University Medical School,undefined
[7] Laikon General Hospital,undefined
来源：
American Journal of Clinical Dermatology | 2008年 / 9卷
关键词：
Fenofibrate; Mycosis Fungoides; Bexarotene; Overall Response; Immune Response Modifier;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background:The new rexinoid bexarotene is a retinoid X receptor antagonist and immune response modifier. Although combinations of oral bexarotene and psoralen plus UVA (PUVA) have been tried in patients with all stages of mycosis fungoides (MF), the dosage of bexarotene used in these combination regimens has been variable.
引用
收藏
页码：169 / 173
页数：4
相关论文
共 50 条
  • [31] Response and local control in patients treated with low-dose radiotherapy for tumoral mycosis fungoides
    Pena, Joseph
    Cull, Deborah
    Strowd, Lindsay
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB103 - AB103
  • [32] Response and local control in patients treated with low-dose radiotherapy for tumoral mycosis fungoides
    Pena, Joseph
    Cull, Deborah
    Strowd, Lindsay C.
    Vaidya, Rakhee
    Seegars, Mary Beth
    Ahn, Christine
    Winkfield, Karen M.
    Hughes, Ryan T.
    LEUKEMIA & LYMPHOMA, 2023, 64 (13) : 2202 - 2207
  • [33] Treatment of refractory stage IV mycosis fungoides with bexarotene monotherapy
    Otremba, Burkhard
    DERMATOLOGIC CLINICS, 2008, 26 (01) : 51 - 52
  • [34] Low-Dose Intralesional Recombinant Interferon-α2b in the Treatment of Mycosis Fungoides
    Hu, Jamie Katy
    Carlson, Kacie
    Girardi, Michael
    YALE JOURNAL OF BIOLOGY AND MEDICINE, 2020, 93 (01): : 41 - 44
  • [35] Efficacy of Low-Dose Ultraviolet A-1 Phototherapy for Parapsoriasis/Early-Stage Mycosis Fungoides
    Aydogan, Kenan
    Yazici, Serkan
    Adim, Saduman Balaban
    Gunay, Isil Tilki
    Budak, Ferah
    Saricaoglu, Hayriye
    Tunali, Sukran
    Baskan, Emel Bulbul
    PHOTOCHEMISTRY AND PHOTOBIOLOGY, 2014, 90 (04) : 873 - 877
  • [36] Bexarotene monotherapy for patients with refractory early stage mycosis fungoides
    Stein, Annette
    DERMATOLOGIC CLINICS, 2008, 26 (01) : 67 - 70
  • [37] Novel Inflammatory Biomarkers in Patients with Mycosis Fungoides Treated with Bexarotene
    Tamer, Funda
    Gulekon, Ayla
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2021, 31 (06): : 716 - 718
  • [38] The efficacy and safety of low-dose sirolimus for treatment of lymphangioleiomyomatosis
    Ando, Katsutoshi
    Kurihara, Masatoshi
    Kataoka, Hideyuki
    Ueyama, Masako
    Togo, Shinsaku
    Sato, Teruhiko
    Doi, Tokuhide
    Iwakami, Shin-ichiro
    Takahashi, Kazuhisa
    Seyamaa, Kuniaki
    Mikami, Masashi
    RESPIRATORY INVESTIGATION, 2013, 51 (03) : 175 - 183
  • [39] Efficacy of low-dose Total Skin Electron Irradiation followed by oral Maintenance Retinoids in Patients with Mycosis Fungoides and Sezary Syndrome
    Elsayad, K.
    Rolf, D.
    Sunderkoetter, C.
    Weishaupt, C.
    Mueller, E.
    Nawar, T.
    Stranzenbach, R.
    Livingstone, E.
    Stadler, R.
    Steinbrinck, K.
    Moritz, R.
    Eich, H. T.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (SUPPL 1) : S172 - S172
  • [40] Successful treatment with PUVA in a Japanese patient with photosensitive mycosis fungoides
    Seki, Yuri
    Makino, Teruhiko
    Ueda, Chieko
    Takegami, Yoshiaki
    Matsui, Kotaro
    Shimizu, Tadamichi
    EUROPEAN JOURNAL OF DERMATOLOGY, 2013, 23 (04) : 559 - 560
12345